Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00227721
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Robert Morris 30
Testing effectiveness (Phase 2)Looking for participantsNCT07589543
What this trial is testing

Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerEpithelial Ovarian Cancer, Fallopian Tube or Peritoneum
Beijing Biotech 42
Early research (Phase 1)Ended earlyNCT05397093
What this trial is testing

ITIL-306 in Advanced Solid Tumors

Who this might be right for
Epithelial Ovarian CancerNon-small Cell Lung CancerRenal Cell Carcinoma
Instil Bio 1
Testing effectiveness (Phase 2)Study completedNCT00436215
What this trial is testing

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmFallopian Tube CancerPrimary Peritoneal Cancer
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)UnknownNCT04376073
What this trial is testing

Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Jihong Liu 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432594
What this trial is testing

Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer

Who this might be right for
High-grade Serous Ovarian Cancer (HGSOC)Fallopian Tube CancersPrimary Peritoneal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 82
Not applicableStudy completedNCT04152941
What this trial is testing

Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients

Who this might be right for
Relapsed Ovarian Cancers Patients
ARCAGY/ GINECO GROUP 130
Testing effectiveness (Phase 2)Study completedNCT01248962
What this trial is testing

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 146
Testing effectiveness (Phase 2)Study completedNCT00301756
What this trial is testing

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Borderline Ovarian Surface Epithelial-Stromal Tumor+5 more
National Cancer Institute (NCI) 32
Large-scale testing (Phase 3)UnknownNCT03705156
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Who this might be right for
Platinum-sensitive Relapsed Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 265
Not applicableEnded earlyNCT00669422
What this trial is testing

ChemoFx® PRO - A Post-Market Data Collection Study

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Precision Therapeutics 2,756
Not applicableLooking for participantsNCT05574673
What this trial is testing

Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT02595892
What this trial is testing

Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian Serous TumorRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+1 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00087087
What this trial is testing

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 51
Not applicableEnded earlyNCT01744821
What this trial is testing

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Northwestern University 7
Not applicableUnknownNCT03000192
What this trial is testing

HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life

Who this might be right for
Breast Cancer FemaleBreast NeoplasmNon-Hodgkin's B-cell Lymphoma+15 more
University Hospital Southampton NHS Foundation Trust 3,000
Testing effectiveness (Phase 2)UnknownNCT04410887
What this trial is testing

Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)

Who this might be right for
Stomach CancerGastric Cancer
Ruijin Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00083928
What this trial is testing

Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels

Who this might be right for
Ovarian CancerPrimary Peritoneal Carcinoma
Ångstrom Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00023712
What this trial is testing

Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Study completedNCT00191607
What this trial is testing

Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Who this might be right for
Genital Neoplasms, FemaleFallopian Tube NeoplasmsOvarian Neoplasms+2 more
Eli Lilly and Company 162
Next Page